"Trifluridine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
| Descriptor ID |
D014271
|
| MeSH Number(s) |
D03.383.742.680.705.900 D13.570.230.855.900 D13.570.685.705.900
|
| Concept/Terms |
Trifluridine- Trifluridine
- Trifluorothymidine
- 2'-deoxy-5-(trifluoromethyl)uridine
- Trifluoridine
- 5-Trifluoromethyl-2'-deoxyuridine
- 5 Trifluoromethyl 2' deoxyuridine
|
Below are MeSH descriptors whose meaning is more general than "Trifluridine".
Below are MeSH descriptors whose meaning is more specific than "Trifluridine".
This graph shows the total number of publications written about "Trifluridine" by people in this website by year, and whether "Trifluridine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Trifluridine" by people in Profiles.
-
How to incorporate a chemo-free interval into the management of metastatic colorectal cancer. Clin Adv Hematol Oncol. 2020 Oct; 18 Suppl 16(10):1-24.
-
Third-line treatments for the management of metastatic colorectal cancer: why to change the mechanism of action after frontline chemotherapy, and insights into management during the COVID-19 pandemic. Clin Adv Hematol Oncol. 2020 10; 18 Suppl 16(10):6-14.
-
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. J Recept Signal Transduct Res. 2020 Dec; 40(6):605-612.
-
TAS-102 in metastatic colorectal cancer. Lancet Oncol. 2018 01; 19(1):e18.
-
A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis. Clin Colorectal Cancer. 2018 06; 17(2):113-120.
-
Metastatic Colorectal Cancer: Management With Trifluridine/Tipiracil?. Clin J Oncol Nurs. 2017 Apr 01; 21(2):E30-E37.
-
Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model. J Virol Methods. 1987 Dec; 18(4):257-69.